Olympus Co. (OTCMKTS:OCPNY – Get Free Report)’s stock price crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $18.00 and traded as low as $18.00. Olympus shares last traded at $18.00, with a volume of 400 shares changing hands.
Olympus Stock Performance
The firm has a market capitalization of $23.15 billion, a PE ratio of 21.95, a price-to-earnings-growth ratio of 1.07 and a beta of 0.70. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.99 and a quick ratio of 1.48. The stock has a 50-day moving average price of $18.00 and a 200-day moving average price of $18.00.
Olympus Company Profile
Olympus Corporation is a Tokyo-headquartered manufacturer specializing in medical and scientific imaging, precision optics and related equipment. The company’s medical systems business is focused on endoscopic technologies and therapeutic devices used in minimally invasive diagnosis and treatment, supplying hospitals and clinical facilities with endoscopes, visualization platforms and accessories. In addition to healthcare, Olympus serves scientific and industrial customers with microscopes, imaging systems, non-destructive testing equipment and precision measurement tools used in research, manufacturing and quality control.
In recent years the company completed a strategic refocus on healthcare and scientific solutions, divesting its consumer camera business in 2020 to concentrate resources on medical device development, services and life-science applications.
Featured Articles
- Five stocks we like better than Olympus
- Wall Street Alert: Buy AES
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- The AI Boom Is Creating a New Kind of Infrastructure Opportunity
- Trump’s Hand-Written Letter Will Shock his Haters
- Bitcoin is down but your income is about to explode
Receive News & Ratings for Olympus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olympus and related companies with MarketBeat.com's FREE daily email newsletter.
